Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (291-300 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|September 19, 2019
DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicityClaudio Sustmann, Steffen Dickopf, Jörg T Regula, et al.
Mabs|July 28, 2019
Site-specific N- and O-glycosylation analysis of ataciceptKathrin Stavenhagen, Rabah Gahoual, Elena Dominguez Vega, et al.
Mabs|March 28, 2014
Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMabLei Zhao, Feiyue Xie, Xin Tong, et al.
Mabs|March 29, 2014
Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coliAdriano Podestà, Serena Rossi, Ilaria Massarelli, et al.
Mabs|January 11, 2017
The making of bispecific antibodiesUlrich Brinkmann, Roland E Kontermann
Mabs|February 7, 2017
Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examplesYi-Fan Zhang, Mitchell Ho
Mabs|January 27, 2017
bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodiesSanket Patke, Ji Li, Peiyin Wang, et al.
Mabs|November 4, 2016
Corrigendum
Mabs|February 5, 2014
Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cellsJeffrey C Kang, Jayakumar S Poovassery, Pankaj Bansal, et al.
Mabs|February 5, 2014
Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin geloninPetra Kornberger, Arne Skerra
Pageof 184

Showing results (291-300 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|September 19, 2019
DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicityClaudio Sustmann, Steffen Dickopf, Jörg T Regula, et al.
Mabs|July 28, 2019
Site-specific N- and O-glycosylation analysis of ataciceptKathrin Stavenhagen, Rabah Gahoual, Elena Dominguez Vega, et al.
Mabs|March 28, 2014
Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMabLei Zhao, Feiyue Xie, Xin Tong, et al.
Mabs|March 29, 2014
Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coliAdriano Podestà, Serena Rossi, Ilaria Massarelli, et al.
Mabs|January 11, 2017
The making of bispecific antibodiesUlrich Brinkmann, Roland E Kontermann
Mabs|February 7, 2017
Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examplesYi-Fan Zhang, Mitchell Ho
Mabs|January 27, 2017
bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodiesSanket Patke, Ji Li, Peiyin Wang, et al.
Mabs|November 4, 2016
Corrigendum
Mabs|February 5, 2014
Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cellsJeffrey C Kang, Jayakumar S Poovassery, Pankaj Bansal, et al.
Mabs|February 5, 2014
Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin geloninPetra Kornberger, Arne Skerra
Pageof 184